Cepheid

Cepheid is a leading innovator in molecular diagnostics, committed to improving healthcare outcomes by providing rapid, accurate, and easy-to-use diagnostic tests. Their flagship GeneXpert® system is a fully automated, scalable platform that integrates sample preparation, amplification, and detection, delivering results in as little as an hour. Cepheid’s portfolio spans a wide range of infectious diseases, including respiratory infections, healthcare-associated infections, blood virology, women's and sexual health, and tuberculosis, as well as oncology and human genetics.

Cepheid's dedication to innovation is evident in their "Lab in a Cartridge™" technology, which simplifies complex procedures and allows for on-demand testing. This approach, coupled with their commitment to global access and collaborations with healthcare providers, has made Cepheid a trusted partner in the fight against infectious diseases and the advancement of personalized medicine. Their acquisition by Danaher Corporation in 2016 further strengthens their position as a global leader in diagnostics and life sciences.

Cepheid appears to offer a variety of flexible work arrangements, although details are limited. Their website emphasizes "groundbreaking work" and the opportunity to "perform groundbreaking work," suggesting a dynamic environment with potentially flexible options. The company's global presence and work in 17 countries with production sites in the US, Sweden, and India, further suggests a degree of geographic flexibility.

Cepheid is a leading molecular diagnostics company committed to improving healthcare by providing access to accurate and rapid testing for a wide range of infectious diseases and genetic conditions. They strive to make molecular diagnostics accessible everywhere, empowering healthcare professionals with the tools to deliver better patient outcomes.

Cepheid fosters a culture of innovation and dedication to improving healthcare. They value collaboration and strive to provide associates with professional development opportunities, empowering them to deliver groundbreaking work. Their focus on creating "A Better Way" for healthcare professionals to access molecular testing reflects a commitment to improving patient outcomes and making a positive impact on the world.

Cepheid is committed to fostering a diverse, equitable, and inclusive workplace. The company prioritizes building a culture where all individuals feel valued, respected, and empowered to contribute their unique talents and perspectives. This commitment is reflected in their efforts to create an inclusive environment, provide equal opportunities for all, and promote diversity in their leadership and workforce.